Key regions: Australia, Brazil, United Kingdom, Europe, Canada
The Other Vaccines market in Uruguay has been showing steady growth in recent years.
Customer preferences: Uruguayan customers are becoming increasingly aware of the importance of vaccination in preventing diseases. This has led to a growing demand for other types of vaccines beyond the traditional ones, such as those for influenza and hepatitis. Additionally, the government has implemented vaccination campaigns, which has further increased public awareness and demand for vaccines.
Trends in the market: The Other Vaccines market in Uruguay has been growing steadily due to several factors. Firstly, the country has a growing population, which has led to an increase in demand for healthcare services, including vaccines. Secondly, the government has been investing in healthcare infrastructure, which has made it easier for people to access vaccines. Thirdly, there has been an increase in the number of private clinics that offer vaccination services, which has further increased access to vaccines.
Local special circumstances: Uruguay has a relatively small population compared to other countries in the region, which has made it easier for the government to implement vaccination campaigns. Additionally, the country has a well-developed healthcare system, which has made it easier for people to access vaccines. Furthermore, the government has implemented policies that prioritize public health, which has led to increased investment in healthcare infrastructure.
Underlying macroeconomic factors: Uruguay has a stable economy, which has contributed to the growth of the Other Vaccines market. Additionally, the country has a well-educated population, which has led to increased awareness of the importance of vaccination. Furthermore, the government has implemented policies that prioritize public health, which has led to increased investment in healthcare infrastructure.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
